Edition:
United Kingdom

scPharmaceuticals Inc (SCPH.OQ)

SCPH.OQ on NASDAQ Stock Exchange Global Market

14.51USD
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
$14.51
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
$18.17
52-wk Low
$13.07

Latest Key Developments (Source: Significant Developments)

Ra Capital Management Reports 16.2 Percent Passive Stake In Scpharmaceuticals
Monday, 11 Dec 2017 

Dec 11 (Reuters) - Scpharmaceuticals Inc ::RA CAPITAL MANAGEMENT, LLC REPORTS 16.2 PERCENT PASSIVE STAKE IN SCPHARMACEUTICALS INC AS OF NOVEMBER 17 - SEC FILING.  Full Article

Sun Pharmaceutical Industries Reports 12.3 Percent Stake In Scpharmaceuticals As Of November 21
Monday, 27 Nov 2017 

Nov 27 (Reuters) - Scpharmaceuticals Inc ::SUN PHARMACEUTICAL INDUSTRIES LIMITED REPORTS 12.3 PERCENT STAKE IN SCPHARMACEUTICALS INC AS OF NOVEMBER 21 - SEC FILING‍​.SUN PHARMACEUTICAL INDUSTRIES LIMITED SAYS PURCHASED SCPHARMACEUTICALS INC'S COMMON STOCK FOR INVESTMENT PURPOSES.  Full Article

ScPharmaceuticals shares debut about 1.8 pct above IPO price
Friday, 17 Nov 2017 

Nov 17 (Reuters) - :ScPharmaceuticals Inc shares open at $14.25 in debut on the NASDAQ versus IPO price of $14.00 per share.  Full Article

ScPharmaceuticals Inc prices IPO of 6.4 mln shares at $14/share
Friday, 17 Nov 2017 

Nov 16 (Reuters) - Scpharmaceuticals Inc -:SCPHARMACEUTICALS INC. ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING.SAYS INITIAL PUBLIC OFFERING OF 6.40 MILLION COMMON SHARES PRICED AT $14.00PER SHARE.  Full Article

Scpharmaceuticals sees IPO of 6.4 mln shares to be priced between $14.00 and $16.00 per share‍​
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Scpharmaceuticals Inc ::Scpharmaceuticals Inc sees IPO of 6.4 million shares of common stock to be priced between $14.00 and $16.00 per share - SEC filing‍​.Scpharmaceuticals Inc says intends to use about $35 million - $42 million of IPO proceeds for pre-commercial planning and commercialization of furoscix.Scpharmaceuticals - intends to use about $6 million-$8 million of IPO proceeds for automation necessary to increase manufacturing capacity for sc2wear infusor.  Full Article

BRIEF-Ra Capital Management Reports 16.2 Percent Passive Stake In Scpharmaceuticals

* RA CAPITAL MANAGEMENT, LLC REPORTS 16.2 PERCENT PASSIVE STAKE IN SCPHARMACEUTICALS INC AS OF NOVEMBER 17 - SEC FILING Source text for Eikon: (http://bit.ly/2Bzh23r) Further company coverage:

No consensus analysis data available.